Qualified participants must:
Basic Criteria
- Are you 18+
- Diagnosed with Type 2 Diabetes
- Currently on name brand Mounjaro or Ozempic as only treatment for T2D for past 5 months, allowing for temporary disruption of up to 2 weeks.
- Must be able to bring in medical records that:
- year diagnosed with diabetes
- start date of Ozempic or Mounjaro
- additional diabetes medications if applicable
- most recent A1c, A1c prior to start Ozempic or Mounjaro
- and weight prior to starting Ozempic or Mounjaro if known (if unknown, this is ok).
- show Mounjaro or Ozempic dates of use
Answers Must Be NO
- Are you pregnant?
- Do you have a cognitive impairment, hearing difficulty, visual impairment, severe psychopathology, or insufficient knowledge of English that would make you unable to complete the study visit and questionnaires
- Are you currently on any medications intended for chronic weight management (including but not limited to Zepbound and Wegovy)?
- Are you diagnosed with type 1 diabetes?
- Are you on a GLP-1 receptor agonist other than Ozempic. Examples include Trulicity, Bydureon, Victoza, and Rybelsus.
- Have you been in another study with investigational product in the last 30 days?
Answers Must be Yes
- Are you able to read and understand study directions?
- If you have access to it, can you bring in your last recorded A1c reading for your visit? (OK, if they don’t have it but preferred) (examples: lab printout or access to it on their phone so they can share during visit and can be printed)
Compensation up to $100 may be available for time and travel.
Insurance is not required.
If you do not see an available appointment, please call 210-714-0067 for availability.
Transportation may be available. Call 210-714-0067.
Schedule Appointment